Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 95.28
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Lactose India Ltd. engages in manufacturing of pharmaceutical and other pharmaceutical products. Its products include Excipient, Solid Dosage, Liquid Dosage, Active Pharmaceutical Ingredients, and Prebiotic-galacto-Oligosaccharides. The company was founded on March 11, 1991 and is headquartered in Mumbai, India.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD.
Data is available to registered users only
Buy
Sell